Baroda BNP Paribas NIFTY 50 Index Fund Regular - IDCW Reinvestment
Baroda BNP Paribas NIFTY 50 Index Fund Regular - IDCW Reinvestment: Mutual Fund Overview
Baroda BNP Paribas NIFTY 50 Index Fund Regular - IDCW Reinvestment is an Large Cap mutual fund with over 2.12 years of performance history. The scheme manages an AUM of ₹63.02 Cr and has a NAV of ₹11.1062. It is rated 'Not Rated' stars by analysts. Investors can begin a SIP with as little as ₹250.0, making it accessible for all types of investors. In the last 1 year, the fund has delivered a return of 6.49%.
Equity, Large Cap, Principal at very high risk
1 Year Return 6.49% at 12 Mar 2026 08:50 PM
Fund Details
NAV 11.1062
Sub-Type Large Cap
Rating Not Rated
Min. SIP Amount ₹250.0
Fund Age(Year) 2.12
Fund Size(in Crores) 63.02
Fund Performance
1 Month -8.1%
3 Month -7.91%
6 Month -4.61%
1 Year 6.49%
3 Year 0.0%
5 Year 0.0%
Know This Fund
As on 12 Mar 2026
Investment strategy that balances risk & reward by dividing the investment portfolio among different types of asset classes.
Equity (97.52%) Market Cap Mid Cap 24.17 Small Cap 36.72 Large Cap 36.63 Top Sectors Healthcare 85.67 Consumer Staples 7.14 Chemicals 1.99 Materials 1.54 Services 1.18 Top Holding Abbott India 1.46 Lupin 2.65 Emcure Pharmaceuticals 3.79 Navin Fluorine International 1.99 Eris Lifesciences 1.08 Shaily Eng Plastics 1.54 Medplus Health Services 1.39 Dr. Lal Pathlabs 1.57 Fortis Healthcare 3.6 Alembic Pharmaceuticals 0.9 Hindustan Unilever 1.16 Neuland Laboratories 3.4 Glaxosmithkline Pharma 1.94 Biocon 1.42 Sanofi Consumer Healthcare India 1.98 Glenmark Pharmaceuticals 1.88 Astrazeneca Pharma India 0.92 Medi Assist Healthcare Services 1.18 Godrej Consumer 1.93 Tata Consumer Products 1.09 Max Healthcare Institute 4.4 Torrent Pharmaceuticals 5.46 Aurobindo Pharma 5.93 Apollo Hospitals Enterprise 6.8 Kwality Wall's (India) 0.01 Sun Pharmaceutical Industries 8.4 Rubicon Research 3.7 Zydus Wellness 2 Vijaya Diagnostic Centre 1.97 Jubilant Pharmova 0.96 Krishna Institute 1.18 Cipla 1.02 Piramal Pharma 6.21 Divi's Laboratories 9.21 Emami 0.95 Ipca Laboratories 2.45
Debt & Others (2.4800000000000004%) Sector Allocation Mutual Fund 1.62 Net Receivables 0.14 CBLO 0.72 Debt Credit Ratings Debt Category Others 0.86 Bajaj Finserv Money Market Direct-G 1.62
Comparison with same funds
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-Growth Ret 1M 1.98% Ret 1Y 11.98% Ret 3Y 24.68% Ret 5Y 14.39%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Ret 1M 1.98% Ret 1Y 11.98% Ret 3Y 24.68% Ret 5Y 14.39%
Equity, Flexi Cap funds Aditya Birla Sun Life Pharma & Healthcare Fund Regular-IDCW Reinvestment Ret 1M 1.98% Ret 1Y 11.98% Ret 3Y 24.68% Ret 5Y 14.39%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-Growth Ret 1M -0.57% Ret 1Y 8.51% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Payout Ret 1M -0.57% Ret 1Y 8.51% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bajaj Finserv Healthcare Fund Regular-IDCW Reinvestment Ret 1M -0.57% Ret 1Y 8.51% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan BSE Healthcare Index Fund Regular-Growth Ret 1M 1.7% Ret 1Y 11.07% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - Growth Ret 1M 1.28% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Ret 1M 1.28% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Bandhan Healthcare Fund Regular - IDCW Reinvestment Ret 1M 1.28% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Equity, Flexi Cap funds Baroda BNP Paribas Health and Wellness Fund Regular-Growth Ret 1M 1.41% Ret 1Y 0% Ret 3Y 0% Ret 5Y 0%
Charges & Taxes Expense Ratio
Returns are taxed as per your Income Tax Slab.
Expense Ratio (Inclusive of GST): 0.56%
Exit Load 0.2%
Stamp Duty 0.005%
Fund Management
The various expenses, charges and taxes associated with your Mutual Fund
Neeraj Saxena
Education He is PGDBA finance and Masters in Organic Chemistry
Experience Prior to joining Baroda BNP Paribas AMC, he has worked with Stratcap Securities, Karvy Stock Broking and Iden Investment Advisors
Riskometer
Mutual Fund Investments are subject to market risk. Read all scheme related documents carefully.
Principal at very high risk
AMC and Fund details
Rank (total sets) 137
Date of Incorporation 2024-01-29
Total AUM 53879.98
The Scheme Seeks to generate returns from a portfolio of pure debt oriented funds accessed through the diverse investment styles of underlying schemes selected in accordance with the BSLAMC process.
Take Your Next Step
